This happens despite the ongoing use of advanced IBD therapies that should still be affecting the germinal center and demonstrates that repeated doses of mRNA vaccines can overcome the lack of TNF-supporting stromal cells in germinal centers. This evidence concerns the gene TNF and inflammatory bowel disease.